Rasch measurement: the Arm Activity measure (ArmA) passive function sub-scale

References

• Ashford S, Slade M, Malaparade F, Turner-Stokes L. Evaluation of functional outcome measures for the hemiparetic upper limb: a systematic review. J Rehabil Med 2008;40:787–95
   PubMed Web of Science ®Google Scholar
• Yelnik AP. Pharmacology and upper limb poststroke spasticity: a review. International Society of Prosthetics and Orthotics. Ann Readapt Med Phys 2004;47:575–89
   PubMedGoogle Scholar
• Dettmers C, Teske U, Hamzei F, et al. Distributed form of constraint-induced movement therapy improves functional outcome and quality of life after stroke. Arch Phys Med Rehabil 2005;86:204–9
   PubMed Web of Science ®Google Scholar
• Page S, Levine P. Forced use after TBI: promoting plasticity and function through practice. Brain Injury 2003;17:675–84
   PubMed Web of Science ®Google Scholar
• Ring H, Rosenthal N. Distributed form of constraint-induced movement therapy improves functional outcome and quality of life after stroke. Arch Phys Med Rehabil 2005;86:204–9
   PubMed Web of Science ®Google Scholar
• van Kuijk AA, Geurts AC, Bevaart BJ, van Limbeek J. Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature. J Rehabil Med 2002;34:51–61
   PubMed Web of Science ®Google Scholar
• van der Lee JH, Beckerman H, Knol DL, et al. Clinimetric properties of the motor activity log for the assessment of arm use in hemiparetic patients. Stroke 2004;35:1–5
   Web of Science ®Google Scholar
• Uswatte G, Taub E, Morris D, et al. The Motor Activity Long-28 Assessing daily use of the hemiparetic arm after stroke. Neurology 2006;67:1189–94
   PubMed Web of Science ®Google Scholar
• Popovic MB, Popovic DB, Sinkjaer T, et al. Clinical evaluation of functional electrical therapy in acute hemiplegic subjects. J Rehabil Res Dev 2003;40:443–53
   PubMed Web of Science ®Google Scholar
• Penta M, Tesio L, Arnould C, et al. The ABILHAND Questionnaire as a measure of manual ability in chronic stroke patients – Rasch-based validation and relationship to upper limb impairment. Stroke 2001;32:1627–34
   PubMed Web of Science ®Google Scholar
• Penta M, Thonnard J-L, Tesio L. ABILHAND: a Rasch-built measure of manual ability. Arch Phys Med Rehabil 1998;79:1038–42
   PubMed Web of Science ®Google Scholar
• Bakheit AMO, Thilmann AF, Ward AB, et al. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 2000;31:2402–6
   PubMed Web of Science ®Google Scholar
• Bakheit AM, Pittock S, Moore AP, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol 2001;8:559–65
   PubMed Web of Science ®Google Scholar
• Bakheit AM, Sawyer J. The effects of botulinum toxin treatment on associated reactions of the upper limb on hemiplegic gait – a pilot study. Disabil Rehabil 2002;24:519–22
   PubMed Web of Science ®Google Scholar
• Bakheit AMO, Fedorova NV, Skoromets AA, et al. The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles. J Neurol Neurosurg Psychiatry 2004;75:1558–61
   PubMed Web of Science ®Google Scholar
• Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. A randomised double blind placebo controlled trial of botulinum toxin treatment on the disabling effects of severe arm spasticity in stroke. Cerebrovasc Dis 1999;9:124
   Google Scholar
• Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Randomized double-blind placebo-controlled trial of botulinum toxin treatment on the disabling effects of severe arm spasticity in stroke. Clin Rehabil 2000;14:213
   Google Scholar
• Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. [erratum appears in J Neurol Neurosurg Psychiatry 2001;70:821]. J Neurol Neurosurg Psychiatry 2000;69:217–21
   PubMed Web of Science ®Google Scholar
• Ashford S, Turner-Stokes L. Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity. Physiother Res Int 2013;18:178–89
   PubMedGoogle Scholar
• Ashford S, Slade M, Turner-Stokes L. Conceptualisation and development of the Arm Activity measure (ArmA) for assessment of activity in the hemiparetic arm. Disabil Rehabil 2013;18:1513–18
   Web of Science ®Google Scholar
• Ashford S, Slade M, Turner-Stokes L. Initial psychometric evaluation of the Arm Activity Measure (ArmA): a measure of activity in the hemiparetic arm. Clin Rehabil 2013;27:728–40
   PubMed Web of Science ®Google Scholar
• Ashford S, Slade M, Nair A, Turner-Stokes L. Arm Activity measure (ArmA) application for recording functional gain following focal spasticity treatment. Int J Ther Rehabil 2014;21:10–17
   Google Scholar
• McPherson K, Berry A, Pentland B. Relationships between cognitive impairments and functional performance after brain injury, as measured by the functional assessment measure (FIM + FAM). Neuropsychol Rehabil 1997;7:241–57
   Web of Science ®Google Scholar
• Forkmann T, Boecker M, Norra C, et al. Development of an item bank for the assessment of depression in persons with mental illness and physical diseases using Rasch analysis. Rehabil Psychol 2009;54:186–97
   PubMed Web of Science ®Google Scholar
• Forkmann T, Boecker M, Wirtz M, et al. Development and validation of the Rasch based depression screening (DESC) using Rasch analysis and structural equation modelling. J Behav Ther Exp Psychiatry 2009;40:469–78
   Web of Science ®Google Scholar
• Nijsten T, Unaeze J, Stern RS. Refinement and reduction of the impact of Psoriasis Questionnaire: classical test theory vs. Rasch analysis. Epidemiol Health Serv Res 2006;154:692–700
   Google Scholar
• Pallant JF, Tennant A. An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS). Br J Clin Psychol 2006;76:781–801
   Google Scholar
• Cano S, Warner TT, Thompson AJ, et al. The Cervical Dystonia Impact Profile (CDIP-58): can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria? Health Qual Life Outcomes 2008;6:58
   PubMed Web of Science ®Google Scholar
• Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: MESA; 1960
   Google Scholar
• Bond T, Fox J. Applying the Rasch model. Fundamental measurement in the human sciences. Toledo: University of Toledo; 2007
   Google Scholar
• ISPM STROBE Statement. University of Bern 2009. Available from: http://www.strobe-statement.org/ [last accessed 4 Aug 2014]
   Google Scholar
• Andersen EB. Sufficient statistics and latent trait models. Psychometrika 1977;42:69–81
   Web of Science ®Google Scholar
• Hobart JC, Cano S. Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess 2009;13:1–200
   Web of Science ®Google Scholar
• Wolf SL, Milton SB, Reiss A, et al. Further assessment to determine the additive effect of Botulinum Toxin Type A on an upper extremity exercise program to enhance function among individuals with chronic stroke but extensor capability. Arch Phys Med Rehabil 2011;93:578–87
   PubMed Web of Science ®Google Scholar
• Khan A, Chien C, Brauer S. Rasch-based scoring offered more precision in differentiating patient groups in measuring upper limb function. J Clin Epidemiol 2013;66:681–7
   PubMed Web of Science ®Google Scholar
• Hobart JC, Cano S, Zajicek JP, Thompson AJ. Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. Lancet Neurol 2007;6:1094–105
   PubMed Web of Science ®Google Scholar
• Hobart JC, Cano S, Thompson AJ. Effect sizes can be misleading: is it time to change the way we measure change. J Neurol Neurosurg Psychiatry 2010;81:1044–8
   PubMed Web of Science ®Google Scholar
• Dickson HG, Kohler F. The multi-dimensionality of the FIM motor items precludes an interval scaling using Rasch analysis [comment]. Scand J Rehabil Med 1996;28:159–62
   PubMedGoogle Scholar
• Penta M, Thonnard J-L, Tesio L. ABILHAND: a Rasch-built measure of manual ability. Arch Phys Med Rehabil 1998;79:1038–42
   PubMed Web of Science ®Google Scholar
• Van de Winckel A, Feys H, van der Knaap S, et al. Can quality of movement be measured? Rasch analysis and inter-rater reliability of the motor evaluation scale for upper extremity in stroke patients (MESUPES). Clin Rehabil 2006;20:871–84
   PubMed Web of Science ®Google Scholar
• Bakheit AM, Zakine B, Maisonobe P, et al. The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey. Int J Rehabil Res 2010;33:119–204
   Web of Science ®Google Scholar
• Siegert R, Jackson D, Tennant A, Turner-Stokes L. Factor analysis and Rasch analysis of the Zarit Burden interview for acquired brain injury carer research. J Rehabil Med 2010;42:302–9
   PubMed Web of Science ®Google Scholar
• Lord FM, Novack TA. Statistical theories of mental test scores. Reading: Addison-Wesley; 1968
   Google Scholar
• Perline R, Wright BD, Wainer H. The Rasch model as additive conjoint measurement. Appl Psychol Meas 1979;3:237–55
   Google Scholar
• Linacre JM. Sample size and item calibration stability. Rasch Meas Trans 1994;7:328
   Google Scholar
• van der Beek N, Hagemans M, van der Ploeg A, et al. The Rasch-built Pompe-specific Activity (R-PAct) scale. Neuromuscular Disord 2013;23:256–64
   PubMed Web of Science ®Google Scholar
• Andrich D, Sheridan B, Luo G. Rasch models for measurement: RUMM2030. Perth: RUMM Laboratory; 2010
   Google Scholar
• Dorans NJ, Holland PW. DIF detection and description: Mantel-Haenszel and standardisation. In: Holland PW, Wainer H, eds. Differential item functioning. Hillsdale: Lawrence Erlbaum Associates; 1993:33–6
   Google Scholar
• Embretson SE. The new rules of measurement. Psychol Assess 1996;8:341–9
   Web of Science ®Google Scholar
• Embretson SE, Reise SP. Item response theory for psychologists. Mahwah (NJ): Lawrence Erlbaum Associates; 2000
   Google Scholar
• Smith E. Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 2002;3:205–31
   PubMedGoogle Scholar
• van Schuur WH. Mokken scale analysis: between the Guttman scale and parametric item response theory. Polit Anal 2003;11:139–63
   Web of Science ®Google Scholar
• Molenaar IW, Sijtsma K, Boer P. Users manual MSP5 for windows; a program for Mokken scale analysis for polytomous items. Groningen, Netherlands: iec ProGAMMA; 2000
   Google Scholar
• Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes on health related quality of life. The remarkable universality of half a standard deviation. Med Care 2003;41:582–92
   PubMed Web of Science ®Google Scholar